July 19, 2013--Dr. Cyrus Poonawalla, founder and Chief Executive of the Serum Institute of India, has said that the company is preparing to sell inactivated polio vaccines (IPV) at nearly half the price of what current IPV is sold to UNICEF for. According to The Economist, "Currently, Sanofi and GlaxoSmithKline are the primary producers of IPV. They sell it to UNICEF for more than $5 per dose, says Mr. Poonawalla. But Serum will now offer it for nearly half that price. And Mr. Poonawalla wants to 'crash' the price further, to $1.60." While at first, Serum will be selling the vaccines at a loss, it is believed that the price reduction will result in a "rapid uptake" of the vaccine. Read more here.